Qinghai Spring Medicinal Resources Technology Co.,Ltd. Class A

Qinghai Spring Medicinal Resources Technology Co.,Ltd. Class A

SSSE:600381
3.68
CNY
-0.16
(-4.17%)
-0.17EPS
2.47BMarket Cap
Qinghai Spring Medicinal Resources Technology Co.,Ltd. Class A
SSE:600381
(Shanghai Stock Exchange)

Recent

price

3.68

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.19
0.93
1.87
0.02
4.24
2.2
1.13
0.8
0.58
0.4
0.21
0.22
0.27
0.37
0.46
0.64
0.45
Revenue per Share
0.49
0.36
-7.23
0.17
0.75
0.56
0.39
0.53
0.12
0.01
-0.54
-0.42
-0.49
-0.46
-0.34
-0.07
-0.16
Basic EPS, GAAP
-1.53
0.14
-3.45
-0.53
-0.37
1.28
0.51
0.12
-0.4
-0.42
-0.47
-0.31
-0.06
0.02
0.13
-0.06
- -
Free Cash Flow per Basic Share
0.16
- -
0.23
0.02
0.75
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
2.37
7.53
-1.12
-0.13
7.39
2.55
2.92
3.67
4.05
4.07
3.52
3.1
2.61
2.15
1.76
1.7
1.6
Book Value per Share
-1.29
5.71
-2.85
-0.14
6.08
2.22
2.63
3.4
3.81
3.88
3.24
2.85
2.47
2.01
1.63
1.59
1.47
Tangible Book Value per Share
185
256
256
199
487
639
628
586
570
581
592
592
587
582
585
533
568
Basic Weighted Avg Shares
219
239
480
4
2,063
1,402
708
471
333
234
124
128
160
214
270
343
253
Sales/Revenue/Turnover
29.22
31.94
-16.33
-1,759.4
19.83
27.01
30.95
31.8
-14.1
-19.5
-82.67
-83.23
-79.95
-50.41
-51.22
0.31
-26.95
Operating Margin (%)
13
13
71
30
40
45
46
44
42
40
42
42
42
28
30
25
- -
Depreciation Expense
90
93
-1,852
33
365
358
245
311
68
6
-320
-249
-288
-268
-199
-37
-93
Net Income, GAAP
16.8
24.14
- -
1.55
15.87
15.23
11.15
9.28
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
40.97
38.78
-385.77
788.49
17.7
25.51
34.59
65.92
20.55
2.48
-257.14
-194.59
-179.52
-125.24
-73.55
-10.87
-36.81
Profit Margin (%)
-441
1,118
-383
61
1,089
1,581
1,766
1,773
1,434
1,230
1,109
970
794
668
494
607
532
Working Capital
395
740
547
- -
- -
- -
- -
- -
- -
- -
1
1
3
10
3
- -
1
LT Debt
419
2,318
-198
50
1,473
1,758
2,004
2,320
2,383
2,389
2,069
1,820
1,533
1,267
1,036
1,000
945
Total Equity
8.3
2.35
- -
1.19
38.55
18.8
11.28
12.45
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
20.2
5.1
- -
47.87
42.02
20.94
13
14.12
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
8.32
- -
- -
- -
22.18
13.05
14.39
2.92
0.24
-14.34
-12.78
-17.15
-19.15
-17.3
-3.68
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
2
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
587
587
587
Market Capitalization
1,791
2,994
2,466

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
632
606
620
Cash, Cash Equivalents & STI
164
249
140
Accounts Receivable, Net
68
58
105
Inventories
143
137
142
Total Current Liabilities
36
32
88
Payables & Accruals
- -
- -
- -
ST Debt
2
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-4.76%
-13.38%
-3.54%
Free Cash Flow
-28.83%
48.41%
-143.34%
Net Income, GAAP
-589.66%
-24.08%
-81.22%
Sales/Revenue/Turnover
-7.38%
23.03%
27.07%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
84
54
60
72
270
2025
84
41
- -
131
343
2026
44
15
63
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.05
-0.06
-0.05
-0.19
-0.34
2025
0.02
-0.01
- -
-0.06
-0.07
2026
-0.03
-0.03
-0.04
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Qinghai Spring Medicinal Resources Technology Co., Ltd. engages in the comprehensive development, production, and distribution of health and wellness products, alongside a robust fast-moving consumer goods segment. The company focuses extensively on ophiocordyceps sinensis products, marketed under the "Verygrass" brand, offering items such as pure powder series and traditional Chinese medicinal formulations. Additionally, it is active in the beverage industry, including alcoholic options like Ting Hua Liquor and the Liang Lu series, emphasizing innovative scientific approaches to product formulation. Established in 2003, this A-share listed entity is headquartered in Xining, China, and is recognized for its commitment to the judicious utilization of natural resources from the Qinghai-Tibet Plateau.